3Spinella PC, Perkins JG, Mc Laughlin DF, et al. The affect of recombinant activated factor VII on mortality in combat related casualties with severe trauma[J]. J Trauma ,2008,64:286-293.
4Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries[J]. New Engl J Med,1994,331:1105-1109.
5Miller DD, Guimond G, Hostler DP,et al. Feasibility of sternal intraosseous access by emergency medical technician students[J]. Prehosp Emerg Care, 2005,9: 73-78.
6Thomas JW,Robert LM. Issues related to the use of tourniquets on the battlefield[J]. Mil Med,2005,170(9) :770.
7Lakstein D, Blumenfeld A, Sokolov T, etal. Tourniquets for hemorrhage control on the battlefield: A 4 year accumulated experience[J]. J Trauma ,2003,54:221-225.
8Butler FK, Holcomb JB, Giebner SD, et al. Tactical combat casualty care 2007:Evolving concepts and battlefield experience[J]. Mil Med,2007,172(1):1-19.
9AlamHB, BurrisD, DaCorta JA,et al. Hemorrhage control in the battlefield:Role of new hemostatic agents[J]. Mil ivied, 2005, 170 (1):63.
10Wedmore I, McManus J, Pusateri A, et al. The chitosan-based he mostatic dressing,Experience in current combat operations: a retrospective review[J]. J Trauma ,2006,60: 655-658.
